| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.07 | 0.1 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.1 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.2 |